^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    AST-021p

    i
    Other names: AST-021p, HSP90 Th1 peptide Vaccine
    Associations

    News

    Trials
    Company:
    Aston Sci.
    Drug class:
    Th1 cell stimulant
    Related drugs:
    Associations

    News

    Trials
    over2years
    AST-021p Study in Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=19, Active, not recruiting, Aston Sci. Inc. | Recruiting --> Active, not recruiting | Trial completion date: Jul 2023 --> Nov 2023 | Trial primary completion date: Mar 2023 --> Aug 2023
    Enrollment closed • Trial completion date • Trial primary completion date • Metastases
    |
    IFNG (Interferon, gamma)
    |
    AST-021p
    over3years
    AST-021p Study in Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=19, Recruiting, Aston Sci. Inc. | Trial completion date: Feb 2023 --> Jul 2023 | Trial primary completion date: Oct 2022 --> Mar 2023
    Trial completion date • Trial primary completion date
    |
    IFNG (Interferon, gamma)
    |
    AST-021p